Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension - Bianchi, G; Czerwinski, E; Kenwright, A (Osteoporos Int, 2012)
PMID: 21975558